Prevention of doxorubicin sorptive losses in drug delivery studies using polyethylene glycol

被引:10
作者
Curry, Dennis [1 ,2 ,3 ]
Scheller, Hope [1 ,2 ]
Lu, Mingsheng [1 ]
Mkandawire, Martin [1 ,4 ]
Servos, Mark R. [3 ]
Cui, Shufen [5 ]
Zhang, Xu [1 ,3 ,4 ]
Oakes, Ken D. [1 ,2 ]
机构
[1] Cape Breton Univ, Verschuren Ctr Sustainabil Energy & Environm, Sydney, NS B1P 6L2, Canada
[2] Cape Breton Univ, Dept Biol, Sydney, NS B1P 6L2, Canada
[3] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada
[4] Cape Breton Univ, Dept Chem, Sydney, NS B1P 6L2, Canada
[5] Shenzhen Polytech, Dept Biol Appl Engn, Shenzhen Key Lab Fermentat Purificat & Anal, Shenzhen 518055, Peoples R China
来源
RSC ADVANCES | 2015年 / 5卷 / 33期
基金
加拿大健康研究院;
关键词
BLOCK-COPOLYMER MICELLES; GOLD NANOPARTICLES; ADSORPTION; AGENT; ENCAPSULATION; DEGRADATION; CONJUGATE; STABILITY; CARCINOMA; PH;
D O I
10.1039/c5ra01799h
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The nonspecific sorption of hydrophobic pharmaceuticals on reaction vessel surfaces raises serious analytical challenges for their accurate quantification. Systematic error due to sorptive loss of analytes may result in significant overestimation of drug loading on nanomaterial-based Drug Delivery Systems (DDS), leading to inaccurate determinations of dosage and DDS efficiency. We evaluated sorptive losses of doxorubicin (DOX), an effective chemotherapeutic, in polystyrene based 96-well plates, and proposed a simple but effective method to prevent the nonspecific sorption of DOX using trace concentrations of polyethylene glycol (PEG). Relative to widely used proteinaceous and surfactant surface blocking agents, PEG is effective, easy to use, and does not interfere with drug loading to the DDS.
引用
收藏
页码:25693 / 25698
页数:6
相关论文
共 29 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform [J].
Bagalkot, Vaishali ;
Farokhzad, Omid C. ;
Langer, Robert ;
Jon, Sangyong .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2006, 45 (48) :8149-8152
[3]   Reduced UV-induced degradation of doxorubicin encapsulated in polyethyleneglycol-coated liposomes [J].
Bandak, S ;
Ramu, A ;
Barenholz, Y ;
Gabizon, A .
PHARMACEUTICAL RESEARCH, 1999, 16 (06) :841-846
[4]   ASPECTS OF THE DEGRADATION KINETICS OF DOXORUBICIN IN AQUEOUS-SOLUTION [J].
BEIJNEN, JH ;
VANDERHOUWEN, OAGJ ;
UNDERBERG, WJM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 32 (2-3) :123-131
[5]   Doxorubicin Cardiomyopathy [J].
Chatterjee, Kanu ;
Zhang, Jianqing ;
Honbo, Norman ;
Karliner, Joel S. .
CARDIOLOGY, 2010, 115 (02) :155-162
[6]   Polyethylene glycol and solutions of polyethylene glycol as green reaction media [J].
Chen, J ;
Spear, SK ;
Huddleston, JG ;
Rogers, RD .
GREEN CHEMISTRY, 2005, 7 (02) :64-82
[7]   Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology [J].
Daniel, MC ;
Astruc, D .
CHEMICAL REVIEWS, 2004, 104 (01) :293-346
[8]   Fluorescence quenching of dye molecules near gold nanoparticles:: Radiative and nonradiative effects -: art. no. 203002 [J].
Dulkeith, E ;
Morteani, AC ;
Niedereichholz, T ;
Klar, TA ;
Feldmann, J ;
Levi, SA ;
van Veggel, FCJM ;
Reinhoudt, DN ;
Möller, M ;
Gittins, DI .
PHYSICAL REVIEW LETTERS, 2002, 89 (20) :203002-203002
[9]   Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling [J].
Fan, Cundong ;
Zheng, Wenjie ;
Fu, Xiaoyan ;
Li, Xiaoling ;
Wong, Yum-Shing ;
Chen, Tianfeng .
ONCOTARGET, 2014, 5 (09) :2853-2863
[10]   EFFECT OF POLY(ETHYLENE GLYCOL) ON THE POLARITY OF AQUEOUS-SOLUTIONS AND ON THE STRUCTURE OF VESICLE MEMBRANES [J].
HERRMANN, A ;
PRATSCH, L ;
ARNOLD, K ;
LASSMANN, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 733 (01) :87-94